Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs PT Telekomunikasi Indonesia Tbk (TLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs PT Telekomunikasi Indonesia Tbk — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.69 (market cap $6.04B), while PT Telekomunikasi Indonesia Tbk trades at $12.87 (market cap $12.43B). The key difference: PT Telekomunikasi Indonesia Tbk is far larger — about 2.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and PT Telekomunikasi Indonesia Tbk pays a 9.48% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and PT Telekomunikasi Indonesia Tbk for 1 Days on average.
| IOVA | TLK | |
|---|---|---|
Market Cap | $6.04B | $12.43B |
Volume | 14,805,993 | 1,067,041 |
Sector | Health | Media |
52-Week High | $14.82 | $23.43 |
52-Week Low | $1.81 | $12.42 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $13.80B |
Dividend Yield | — | 9.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About PT Telekomunikasi Indonesia Tbk
Telkom Indonesia provides mobile, fixed-line, broadband, and digital services in Indonesia. Its businesses include Telkomsel, which serves the country’s mobile market.
Read more on TLK →
